stocktools
Dilution profile // every instrument, one screen, from SEC filings

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

CIK 1877184 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$163M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW+14% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
LOW~28.9 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2025-04-172026-07-09

Latest: 58.6M shares as of Jul 9, 2026 (10-K).

Cash runway

Self-funding

generates cash

Full breakdown: cash runway tool · source filing →

Warrants

Balance-sheet fair value of warrants: $1.4M as of Apr 30, 2026.

Convertible notes

No convertible-note facts tagged in the 10-K filed Jul 14, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $162.9Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3ASRApr 1, 2026fee exhibit found but no total offering amount (fees deferred, typical for automatic shelves)filing →
S-1Dec 1, 2025$162.9M registeredfiling →
S-1Feb 10, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 1 executed · 3 registered.

REGISTEREDApr 1, 2026Automatic shelf registration — effective immediately (large filers)S-3ASR →
EXECUTEDDec 3, 2025Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDDec 2, 2025S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF →
EFFECTIVEDec 2, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDDec 1, 2025S-1 registration — capacity to sell shares, not a sale yetS-1 →
EXECUTEDMar 6, 2025Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDMar 5, 2025S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF →
EFFECTIVEMar 5, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMar 3, 2025S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDFeb 26, 2025S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDFeb 10, 2025S-1 registration — capacity to sell shares, not a sale yetS-1 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full KMTS workspace